A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Children With Gaucher Disease Under 5 Years Old
Condition: Gaucher Disease Intervention: Other: Standard of Care Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials